Pantoprazole Sodium Tablet, Delayed Release
Product Images NDC 42708-104

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pantoprazole Sodium (NDC 42708-104). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Qpharma Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Address1.jpg (Address1)

FDA Label Image

Address2.jpg (Address2)

FDA Label Image

42708-104-30 Pantoprazole Sodium Tablet Delayed-release Usp 40mg X 30 (Pantoprazole40mgcontlabel)

Label for Pantoprazole Sodium Tablet, Delayed-Release USP, 40 mg, containing 30 tablets. The label includes dosage instructions to be filled in, store at controlled room temperature, and states it is Rx only. Distributed by QPharma, Inc, Cedar Knolls, NJ.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure of pantoprazole sodium depicted with its molecular components, including fluorine atoms, sodium ion, and methoxy groups, consistent with the 40 mg delayed-release tablet formulation by QPharma Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.